The HPV Vaccine – Will It Make Its Way To India’s Medical Cabinets? - Acrindia - PowerPoint PPT Presentation

About This Presentation
Title:

The HPV Vaccine – Will It Make Its Way To India’s Medical Cabinets? - Acrindia

Description:

With 70,000 women dying of cervical cancer every year in India, there should be efforts made to bring a stop to such fatal deaths. With the HPV vaccine being introduced, we have to see if it can gain acceptance to go public. – PowerPoint PPT presentation

Number of Views:7
Slides: 3
Provided by: AvignaResearch
Category:

less

Transcript and Presenter's Notes

Title: The HPV Vaccine – Will It Make Its Way To India’s Medical Cabinets? - Acrindia


1
Almost 70,000 women die every year in India
because of the dangerous disease which is known
as cervical cancer! To reduce or eliminate this
number, a lifesaving vaccine known as human
papillomavirus (HPV) has been found, but hasnt
yet been approved to be used publicly.
Cervical cancer is one of the leading threats to
womens health, which kills one Indian woman in
every 8 minutes! This has made cervical cancer
one of the centurys most lethal cancers. In
fact, it accounts for the second highest number
of cancer related deaths. It has been predicted
that if no step is taken to eliminate this fatal
disease, there would be more than 40 million
cervical cancer deaths worldwide between 2020 and
2069! This is why it is very important to expand
prevention programmes in the next few years to
reduce the number of cervical cancer deaths. One
step towards achieving this can be HPV
vaccination. This vaccine has the potential to
drive down cervical cancer rates to the extent
that it would even disappear, with no tag of
being a threat anymore, by the end of this
century. In the process, millions of women can be
saved against such fatal deaths. India accounts
for a quarter of cervical cancer related deaths
worldwide, making it the
2
country with the highest percentage of such
deaths. Even then, there is no sign of
introducing this vaccine in the country. There
are two HPV types 16 and 18 that are
responsible for 70 of cervical cancer cases.
People with such cancers may also be prone to
getting cancers in the anus, penis, vulva,
vagina, mouth, and throat. Researchers estimate
that using this new HPV vaccine can protect
against these six strains of cancers and many
others, thus preventing 90 of cervical cancers
worldwide. It has been found that the HPV
vaccine is effective as a protective measure
against cancer, making it very easy to mitigate
cervical cancer. Then why isnt India including
this vaccine into its Universal Immunization
Programme? This is not yet being understood.
Public health experts have recommended efforts to
be put in to bring in this vaccine to serve the
public, after checking for all its pros and
cons. All we can do is wait and watch as to
whether or not, and when this vaccine will enter
the market. We can just pray that this vaccine
proves its point completely so that 70,000 of
our women can be saved every year. However, if
you are passionate about putting in your efforts
to save your people not only against deadly
deaths related to cervical cancers, but many
other ailments, you must take up clinical
research as your career option. And for that,
you must get enrolled with one of the best
clinical research institutes in Bangalore.
Avigna Clinical Research Institute is one
institution you can rely upon, where you can be
taught a self-designed up-to-date
industry-integrated curriculum by reputed
professionals, while also being sure to be 100
placed in top CROs, Bio-techs, and
pharmaceutical companies after completing your
course.
Write a Comment
User Comments (0)
About PowerShow.com